AAAAAA
Results:
1-7
|
Results: 7
Authors:
Lisse, J
Espinoza, L
Zhao, SZ
Dedhiya, SD
Osterhaus, JT
Citation: J. Lisse et al., Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib, J GERONT A, 56(3), 2001, pp. M167-M175
Authors:
Ernst, ME
Doucette, WR
Dedhiya, SD
Osterhaus, MC
Kumbera, PA
Osterhaus, JT
Townsend, RJ
Citation: Me. Ernst et al., Use of point-of-service health status assessments by community pharmaciststo identify and resolve drug-related problems in patients with musculoskeletal disorders, PHARMACOTHE, 21(8), 2001, pp. 988-997
Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib
Authors:
Zhao, SZ
Fiechtner, JI
Tindall, EA
Dedhiya, SD
Zhao, WW
Osterhaus, JT
Yu, SS
Citation: Sz. Zhao et al., Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib, ARTH C RES, 13(2), 2000, pp. 112-121
Authors:
Zhao, SZ
Arguelles, LM
Dedhiya, SD
Morgan, DG
Citation: Sz. Zhao et al., Healthcare utilization associated with dyspepsia in patients with arthritis, AM J M CARE, 5(10), 1999, pp. 1285-1295
Authors:
Zhao, SZ
McMillen, JI
Markenson, JA
Dedhiya, SD
Zhao, WW
Osterhaus, JT
Yu, SS
Citation: Sz. Zhao et al., Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib, PHARMACOTHE, 19(11), 1999, pp. 1269-1278
Authors:
Zhao, SZ
Dedhiya, SD
Bocanegra, TS
Fort, JG
Kuss, ME
Rush, SM
Citation: Sz. Zhao et al., Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee, CLIN THER, 21(1), 1999, pp. 205-217
Authors:
Simon, LS
Zhao, SZ
Arguelles, LM
Lefkowith, JB
Dedhiya, SD
Fort, JG
Johnson, KE
Citation: Ls. Simon et al., Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis, CLIN THER, 20(6), 1998, pp. 1218-1235
Risultati:
1-7
|